Skip to main content

Walleye Capital LLC

Position in AVXL — Anavex Life Sciences Corp.

CIK 1758720 NEW YORK, NY

Position in AVXL

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,221
-$20,171 QoQ
Shares Held
398
-93.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Derivatives in AVXL

reported options exposure · as of Mar 31, 2026
CallValue
$124,642
CallShares
40,600
PutValue
$77,671
PutShares
25,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Walleye Capital LLC holds $278,334,962 across 104 Biotechnology names. AVXL ranks #103 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVXL

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,221 398
2026-03-31 $124,642 40,600
2026-03-31 $77,671 25,300
2025-12-31 $21,392 6,009
2025-12-31 $71,200 20,000
2025-12-31 $124,600 35,000
2025-03-31 $202,488 23,600
2025-03-31 $97,812 11,400
2024-12-31 $108,474 10,100
2024-12-31 $343,680 32,000
2024-06-30 $320,298 75,900
2024-06-30 $98,748 23,400
2024-03-31 $410,763 80,700
2024-03-31 $132,849 26,100
2023-12-31 $198,303 21,300
2023-12-31 $107,065 11,500
2023-06-30 $77,235 9,500
2023-06-30 $12,195 1,500
2023-03-31 $253,672 29,600
2023-03-31 $21,425 2,500